Commutability Assessment of Processed Human Plasma Samples for Normetanephrine and Metanephrine Measurements Based on the Candidate Reference Measurement Procedure
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: To identify candidate external quality assessment (EQA) materials for normetanephrine and metanephrine measurements, we assessed the commutability of eight processed human plasma samples. The agreement between routine assays and the candidate reference measurement procedure (cRMP) was also evaluated. Methods: Fifty-three clinical samples and eight processed plasma samples were prepared. The processed samples included pooled and individual plasma samples spiked with pure normetanephrine and metanephrine and non-spiked pooled and individual plasma samples. The clinical and processed samples were subjected to four routine isotope dilution tandem mass spectrometry assays and cRMP. Commutability was assessed based on two approaches recommended by the CLSI and International Federation of Clinical Chemistry (IFCC). Passing–Bablok regression and Bland–Altman analysis were used to evaluate the agreement between the routine assays and cRMP. Results: The commutability results of the CLSI approach were better than those of the IFCC approach. For the CLSI approach, spiked individual plasma samples and spiked high-concentration pooled plasma samples were commutable for all routine assays for both analytes. The non-spiked pooled plasma sample was commutable for two out of four routine assays for metanephrine and three out of four routine assays for normetanephrine. The agreement between the routine assays and the cRMP was satisfactory, except for one routine assay showing significant bias. Conclusions: High-concentration spiked pooled plasma samples and spiked individual plasma samples are candidate EQA materials for normetanephrine and metanephrine measurements.
Abstract
Background: To identify candidate external quality assessment (EQA) materials for normetanephrine and metanephrine measurements, we assessed the commutability of eight processed human plasma samples. The agreement between routine assays and the candidate reference measurement procedure (cRMP) was also evaluated. Methods: Fifty-three clinical samples and eight processed plasma samples were prepared. The processed samples included pooled and individual plasma samples spiked with pure normetanephrine and metanephrine and non-spiked pooled and individual plasma samples. The clinical and processed samples were subjected to four routine isotope dilution tandem mass spectrometry assays and cRMP. Commutability was assessed based on two approaches recommended by the CLSI and International Federation of Clinical Chemistry (IFCC). Passing–Bablok regression and Bland–Altman analysis were used to evaluate the agreement between the routine assays and cRMP. Results: The commutability results of the CLSI approach were better than those of the IFCC approach. For the CLSI approach, spiked individual plasma samples and spiked high-concentration pooled plasma samples were commutable for all routine assays for both analytes. The non-spiked pooled plasma sample was commutable for two out of four routine assays for metanephrine and three out of four routine assays for normetanephrine. The agreement between the routine assays and the cRMP was satisfactory, except for one routine assay showing significant bias. Conclusions: High-concentration spiked pooled plasma samples and spiked individual plasma samples are candidate EQA materials for normetanephrine and metanephrine measurements.
참고문헌 (18)
- Tevosian SG, "Pheochromocytomas and paragangliomas", Endocrinol Metab Clin, 48, pp.727~750 (2019)
- Lenders JW, "Pheochromocytoma and paraganglioma : an endocrine society clinical practice guideline", J Clin Endocrinol Metab, 99, pp.1915~1942 (2014)
- Megías MC, "Pheochromocytoma-paraganglioma : biochemical and genetic diagnosis", Nefrologia, 36, pp.481~488 (2016)
- Peaston RT, "Measurement of catecholamines and their metabolites", Ann Clin Biochem, 41, pp.17~38 (2004)
- Eisenhofer G, "Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease : plasma versus urinary free or deconjugated O-methylated catecholamine metabolites", Clin Chem, 64, pp.1646~1656 (2018)
- Därr R, "Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma : a systematic review", Endocrine, 56, pp.495~503 (2017)
- Cobbaert C, "Systematic monitoring of standardization and harmonization status with commutable EQA-samples–five year experience from the Netherlands", Clin Chim Acta, 414, pp.234~240 (2012)
- Zhang S, "Commutability of possible external quality assessment materials for cardiac troponin measurement", PLoS One, 9, pp.e102046~ (2014)
- Meng Q, "Serum triglyceride measurements : the commutability of reference materials and the accuracy of results", Clin Chem Lab Med, 55, pp.1284~1290 (2017)
- Camara JE, "Assessment of serum total 25-hydroxyvitamin D assay commutability of Standard Reference Materials and College of American Pathologists Accuracy-Based Vitamin D(ABVD)Scheme and Vitamin D External Quality Assessment Scheme(DEQAS)materials : Vitamin D Standardization Program(VDSP)Commutability Study 2", Anal Bioanal Chem, 413, pp.5067~5084 (2021)
- Liu Z, "Quantitation of plasma metanephrines using isotope dilution liquid chromatography tandem mass spectrometry(ID-LC", MS, MS, pp.MS methods, Anal Bioanal Chem[DOI]
- CLSI, "Characterization and qualification of commutable reference materials for laboratory medicine; approved guideline" (2010), Clinical and Laboratory Standards Institute
- Miller WG, "IFCC working group recommendations for assessing commutability Part 1 : General experimental design", Clin Chem, 64, pp.447~454 (2018)
- Nilsson G, "IFCC working group recommendations for assessing commutability Part 2 : using the difference in bias between a reference material and clinical samples", Clin Chem, 64, pp.455~464 (2018)
- Budd JR, "IFCC working group recommendations for assessing commutability Part 3 : using the calibration effectiveness of a reference material", Clin Chem, 64, pp.465~474 (2018)
- CLSI, "Measurement procedure comparison and bias estimation using subject samples, approved guideline" (2013), Clinical and Laboratory Standards Institute
- Deprez L, "Commutability assessment of candidate reference materials for pancreatic α-amylase", Clin Chem, 64, pp.1193~1202 (2018)
- Peitzsch M, "Harmonization of LC-MS", MS measurements of plasma free normetanephrine, metanephrine, and 3-methoxytyramine, 2021, pp.67, 1098~1112